Within The S.H.I.V.A. Method™, STIMPOD® is never used as a standalone or symptom-chasing modality. It is applied strategically based on neurological timing, tissue readiness, and system-level regulation.
We don’t just apply neuromodulation , we know when, where, and why to introduce it.
STIMPOD® is introduced to normalize neural signaling and reduce protective nervous system overdrive, preparing the body for deeper regenerative work.
It enhances autonomic balance, improves circulation, and quiets inflammatory reflexes that block tissue repair.
STIMPOD® supports neuromuscular re-education, motor control, and safe progression into movement, load, and functional retraining.
When paired with therapies such as Focused Shockwave, INDIBA, Class IV Laser, EMTT, or manual therapy, STIMPOD® acts as a neurological amplifier, improving outcomes across the entire regenerative process.
STIMPOD® may be ideal if you:
Have nerve-related pain that hasn’t responded to traditional therapy
Experience burning, tingling, numbness, or hypersensitivity
Have chronic pain with an autonomic or stress component
Are recovering from surgery or injury involving nerve irritation
Prefer non-invasive, drug-free treatment options
Individuals hoping to avoid injections, painkillers, or surgery as part of their recovery plan.
STIMPOD® is safe for most adults when applied by trained clinicians and tailored to individual neurological profiles.
STIMPOD® treatments are comfortable, targeted, and designed to support neuroregulation without the need for invasive procedures or downtime. Here’s what a typical session includes:
Each session lasts approximately 10–15 minutes, depending on the condition being treated and its chronicity.
Most patients receive STIMPOD® 1–2 times per week as part of a structured recovery plan.
You may feel a light tapping, pulsing, or twitching sensation beneath the electrode, this is a sign that the nerve is responding.
No need to undress. One stationary grounding pad is placed on the skin, while a handheld pen-like probe is applied with conductive gel to target treatment areas.
Most patients benefit from4 to 5 sessions, while chronic or long-standing conditions may require a longer or phased treatment plan for sustained relief.
There is no downtime. Patients typically return to normal activities immediately following treatment.
Many patients notice reduced pain or improved nerve comfort within the first few sessions, with continued improvement as neural regulation stabilizes.
No. STIMPOD® is designed to be comfortable and non-irritating. It avoids painful nerve stimulation and does not rely on forceful muscle contractions.
Stimpod’s therapeutic efficacy is backed by multiple published studies, including:
Dr. Robert Becker’s pioneering research demonstrated the role of endogenous electrical currents in tissue regeneration and nerve repair, establishing a foundation for neuromodulation techniques like STIMPOD®.
This study reviewed the molecular and cellular impact of electromagnetic fields, including improved calcium ion signaling, altered gene expression, and modulation of nitric oxide—all relevant to STIMPOD’s mechanism.
Clinical case reports have shown near-immediate motor recovery in foot drop and chronic neuropathies, highlighting its regenerative potential via pulsed electromagnetic stimulation.
Multiple studies validate PRF’s effectiveness for chronic pain, showing downregulation of inflammatory cytokines and support for neuroplasticity without neurodestructive effects.
This study reviewed the molecular and cellular impact of electromagnetic fields, including improved calcium ion signaling, altered gene expression, and modulation of nitric oxide—all relevant to STIMPOD’s mechanism.
Clinical case reports have shown near-immediate motor recovery in foot drop and chronic neuropathies, highlighting its regenerative potential via pulsed electromagnetic stimulation.
Multiple studies validate PRF’s effectiveness for chronic pain, showing downregulation of inflammatory cytokines and support for neuroplasticity without neurodestructive effects.
Studies demonstrate how non-invasive stimulation of vagal and autonomic nerves (e.g., with STIMPOD®) can reduce systemic inflammation via the cholinergic anti-inflammatory pathway.
Studies on external, pulsed nerve stimulation demonstrate changes in pain signaling and sensory nerve function, lending mechanistic support to how devices like STIMPOD® can improve chronic neuropathic symptoms.
This study reviewed the molecular and cellular impact of electromagnetic fields, including improved calcium ion signaling, altered gene expression, and modulation of nitric oxide—all relevant to STIMPOD’s mechanism.